LONDON–(BUSINESS WIRE)–The first UK clinical trials of a nasal spray proven to kill 99.9% of the coronavirus that causes Covid-19 will begin on January 11th at Ashford and St Peter’s Hospitals NHS Foundation Trust, in Surrey.
Read more here.
LONDON–(BUSINESS WIRE)–The first UK clinical trials of a nasal spray proven to kill 99.9% of the coronavirus that causes Covid-19 will begin on January 11th at Ashford and St Peter’s Hospitals NHS Foundation Trust, in Surrey.
Read more here.
![[enVerid in PR Newswire] U.S. Department of Energy Study Highlights Energy Savings Potential of Sorbent Ventilation Technology™](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
